About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Development Agreement with tesa Labtec for TPM/Oxymorphone Patch

October 22, 2015

Click here to read more

Post navigation

Phosphagenics Restructures

Phosphagenics Newsletter October 2015

Related Posts

2016 July 29 CEO Quarterly Update

July 29, 2016

Investor Presentation April 2018

April 17, 2018

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.